Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective studyKazuhiro Takahashi, Takahiro Kimura, Yuhei Koike et al.|Japanese Journal of Clinical Oncology|2023Cited by 13
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort studyHirokazu Kagawa, Fumihiko Urabe, Yuria Kiuchi et al.|International Journal of Clinical Oncology|2023Cited by 10
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective studyShuhei Hara, Takahiro Kimura, Keiichiro Mori et al.|International Journal of Clinical Oncology|2024Cited by 9
Prognostic significance of subclassifying pathological <scp>T3</scp> upper tract urothelial carcinoma: Results from a multicenter cohort studyYushi Suhara, Fumihiko Urabe, Kentaro Yoshihara et al.|International Journal of Urology|2023Cited by 8
Effect of a variant histology on the oncological outcomes of Japanese patients with upper tract urothelial carcinomas after radical nephroureterectomy: a multicenter retrospective studyTakahiro Kimura, Naoki Uchida, Fumihiko Urabe et al.|Translational Andrology and Urology|2024Cited by 5